Transforming growth factor beta increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts
about
Transforming growth factor-beta complexes with thrombospondinThrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanismRegulation of HEF1 expression and phosphorylation by TGF-beta 1 and cell adhesionFibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions.Co-assembly of plasma and cellular fibronectins into fibrils in human fibroblast culturesScleroderma and malignancy: an epidemiological studyTGF-β triggers rapid fibrillogenesis via a novel TβRII-dependent fibronectin-trafficking mechanism.Fibronectin matrix turnover occurs through a caveolin-1-dependent process.Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expressionType I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repairInhibition of binding of fibronectin to matrix assembly sites by anti-integrin (alpha 5 beta 1) antibodies.Modulation of cell surface fibronectin assembly sites by lysophosphatidic acid.The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1.Assembly of fibronectin into extracellular matrix.Matrix elasticity, cytoskeletal tension, and TGF-beta: the insoluble and soluble meet.Controlled growth factor delivery for tissue engineering.Fibronectin-dependent collagen I deposition modulates the cell response to fibronectin.Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.Non-uniform influence of transforming growth factor-beta on the biosynthesis of different forms of small chondroitin sulphate/dermatan sulphate proteoglycan.Basolateral distribution of fibronectin matrix assembly sites on vascular endothelial monolayers is regulated by substratum fibronectin.PEGylated human plasma fibronectin is proteolytically stable, supports cell adhesion, cell migration, focal adhesion assembly, and fibronectin fibrillogenesis.Proteolytically stabilizing fibronectin without compromising cell and gelatin binding activity.Morphea with high titer of fibronectin antibodies.
P2860
Q24642789-D170A80A-7244-4A3C-A8EB-C2226974BFB7Q24674746-5C45E623-77D2-4281-877C-3CB3B7BEE1BEQ28218641-ADFC9DA8-C131-473A-B2E4-6927ED85538FQ28575990-DEF0D385-6128-4A28-AFA2-A6C6B416041CQ28756471-03914C5C-5121-400B-8B1D-6B85F5F1E832Q33565616-24BA47D3-8364-4B28-9A4A-2BDE647126ACQ33632419-AE9D6957-7D91-4A45-9D05-5D569590E7EDQ33763861-231E0C6E-C1C5-42A1-9688-EBB8F1F310EEQ34441627-1E5FD4B9-17C8-4B51-9F69-EBAD1094B84DQ35765279-9E5DFD5B-55EB-428A-982C-8495155F4B55Q36223428-CAF67D33-8612-4610-BB64-3FCE65A47E5FQ36234881-612C0618-A4DF-4697-90A1-AA31F60E8372Q36288284-C564BC53-6569-4BE3-8571-EE7070E18F41Q36494019-9724BDC2-CCE9-48D5-9DD8-D6026FF516A3Q37107746-7A7C0A8E-3B9E-40EC-B560-68150B8F39BCQ37794872-3C316EF2-780C-4E47-8102-39D3F43660EDQ40069445-06D93441-B120-46AC-9F28-8C8ABF634602Q41357814-BE917A0B-AC57-4E6D-99D4-0F426BCF3D74Q41728016-DD0826D6-14FC-4D8A-849E-8441F7A6183FQ42454559-06DF6B80-E7AA-48DB-8892-0BD8B139CE0EQ42826722-CE8AF3F0-9018-4565-961C-C9363A9F851CQ42833706-500C784F-95B5-496B-AF87-41FDA152B3A2Q44840820-296F141F-F566-4C12-8EE7-52FF735E6243
P2860
Transforming growth factor beta increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Transforming growth factor bet ...... in by normal human fibroblasts
@en
type
label
Transforming growth factor bet ...... in by normal human fibroblasts
@en
prefLabel
Transforming growth factor bet ...... in by normal human fibroblasts
@en
P2093
P2860
P356
P1476
Transforming growth factor bet ...... in by normal human fibroblasts
@en
P2093
B L Allen-Hoffmann
C L Crankshaw
D F Mosher
P2860
P304
P356
10.1128/MCB.8.10.4234
P407
P577
1988-10-01T00:00:00Z